Advocacy Campaigns
Active Advocacy Campaigns
Active Advocacy Campaigns
Urge Congress to Take Action and Stop the Implementation of the Trump Administration Rule to Change Grant Process
Urge Congress to Take Action and Stop the Implementation of the Trump Administration Rule to Change Grant Process
The Trump Administration has proposed a new rule that applies to all federal agencies and would dramatically reshape the federal grant-making process. The changes proposed by the Office of Management and Budget (OMB), which include limiting scientific dissemination and allowing federal agencies to terminate grants at will, threaten to undermine hematology research and patient care.
Cosponsor the Sickle Cell Disease Comprehensive Care Act
Cosponsor the Sickle Cell Disease Comprehensive Care Act
ASH has been working with congressional sickle cell disease (SCD) champions on bipartisan legislation to improve care for individuals with SCD. The Sickle Cell Disease Comprehensive Care Act (S. 721 / H.R. 5178) expands the existing Medicaid Health Home program. We need your help in getting your elected officials to cosponsor this legislation.
Take Action to Protect Research Funding
Take Action to Protect Research Funding
ASH is the leading advocate for hematologists in Washington, even in light of repeated attempts to cut federal research funding. ASH is calling on you to help support our mission by using your voice. Urge your lawmakers to reject NIH cuts and support strong, sustained research funding.
Take Action in Support of Access to Care by Opposing Funding Cuts to Medicaid
Take Action in Support of Access to Care by Opposing Funding Cuts to Medicaid
As Congress explores options to offset the current administration’s budget priorities through the Congressional budget reconciliation process, one area under consideration is Medicaid funding. Medicaid provides health care coverage to one in five Americans – more than 79 million people.
Take Action to Help Protect Critical Federal Workforce and Infrastructure
Take Action to Help Protect Critical Federal Workforce and Infrastructure
ASH is extremely concerned about the steps the Administration continues to take to radically restructure the U.S. Department of Health and Human Services (HHS), eliminate critical programs, and significantly reduce the federal workforce. This includes devastating changes to agencies with programs critical to hematology, including the Centers for Disease Control & Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), Centers for Medicare & Medicaid Services (CMS), and more. The Society is continuing to try to understand the impact that these changes have had and will have on hematology-related research, public health programs, and patient care.
Improving Access to Transfusion Care for Hospice Patients Act
Improving Access to Transfusion Care for Hospice Patients Act
The Improving Access to Transfusion Care for Hospice Patients Act (S. 1936) has been introduced in the U.S. Senate by Senators Jacky Rosen (D-NV), John Barrasso (R-WY), and Tammy Baldwin (D-WI). This bipartisan bill aims to increase access to palliative blood transfusions for patients receiving end-of-life care through the Medicare hospice benefit by establishing a demonstration program to provide a separate payment for blood transfusions in addition to the daily reimbursement rate for hospice care services.
Latest Impact
ASH Advocacy's Latest Impact on Hematology
ASH Advocacy's Latest Impact on Hematology
Federal Rule Summaries
Federal Rule Summaries
See summaries of the latest rules on hematology-related topics.
Policy Statements
Policy Statements
Explore ASH's statements regarding research, practice, training, and quality of care within the field.
Testimony and Correspondence
Testimony and Correspondence
View formal congressional testimony and correspondence related to issues affecting hematologists and their patients.
Advocacy Priorities
Advocacy Priorities
Advocacy Priorities
Workshops
ASH Congressional Fellowship
ASH Congressional Fellowship
The ASH Congressional Fellowship is a yearlong opportunity that allows an ASH member to work in a congressional office on Capitol Hill, Washington, DC, for an academic year to help shape health care and hematology policy.
Advocacy Leadership Institute (ALI)
Advocacy Leadership Institute (ALI)
ALI is a two-day workshop in Washington, DC, where ASH members can gain a better understanding of the Society, learn about how Congress and health policy impact hematology research and practice, and meet with members of Congress and their staff on Capitol Hill.
ASH-FDA Collaboration
ASH-FDA Collaboration
This Collaboration is a two-day workshop in Washington, DC, co-hosted by the U.S. Food and Drug Administration, for ASH members to network with FDA staff and learn about clinical and translational research, drug development, and regulatory medicine.